The Effect of Metacognition-based, Manualized Intervention on Fear of Cancer Recurrence
-
- STATUS
- Recruiting
-
- End date
- Dec 31, 2023
-
- participants needed
- 174
-
- sponsor
- The University of Hong Kong
Summary
The primary aim of this study is to assess the effect of ConquerFear, a metacognition-based manualized intervention on fear of cancer recurrence, using the randomized controlled trial approach, among Chinese patients newly diagnosed with curable cancer. This study aims to (1) test the direct effect of ConquerFear intervention on fear of cancer recurrence and on maladaptive metacognition, and (2) to test the indirect effect of ConquerFear intervention on fear of cancer recurrence through its effect on maladaptive metacognition.
Description
A randomized controlled trial will be conducted to test the effect of a metacognition-based manualized intervention on fear of cancer recurrence among Chinese breast, gynecologic and colorectal cancer patients with high levels of fear of cancer recurrence.
The aims are to test:
- the direct effect of ConquerFear intervention on fear of cancer recurrence,
- the direct effect of ConquerFear intervention on maladaptive metacognition
- the indirect effect of ConquerFear intervention on fear of cancer recurrence through its effect on maladaptive metacognition.
Primary hypothesis:
- Participants in the ConquerFear intervention will show a greater reduction in fear of cancer recurrence compared to participants in the control group
- Participants in the ConquerFear intervention will show a greater reduction in maladaptive metacognition than the control participants
- There will be an indirect effect of ConquerFear intervention on fear of cancer recurrence through its effect on maladaptive metacognition.
Details
| Condition | Fear of Cancer Recurrence |
|---|---|
| Treatment | ConquerFear Intervention, Active control: Basic Cancer Care |
| Clinical Study Identifier | NCT04568226 |
| Sponsor | The University of Hong Kong |
| Last Modified on | 27 June 2022 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer